8-K: NRC Health Announces First Quarter 2024 Results, Appoints New Principal Financial Officer

National Research Corporation, now known as NRC Health, reported its first quarter 2024 financial results, including a decrease in revenue and net income compared to the same period last year, while also announcing the appointment of Linda Stacy as Principal Financial Officer.

Summary

• National Research Corporation, operating as NRC Health, announced its financial results for the first quarter of 2024.
• The company's revenue for the quarter was $35.3 million, down from $36.5 million in the same quarter of the previous year.
• Net income for the quarter was $6.4 million, compared to $7.0 million in the first quarter of 2023.
• The company returned $18 million to stockholders through dividends and stock repurchases during the quarter.
• NRC Health invested $4 million in organic innovation and growth, including facilities improvements and Human Understanding solutions.
• The company had approximately $40 million of net debt as of March 31, 2024.
• A quarterly cash dividend of $0.12 per share was declared, payable on July 15, 2024, to shareholders of record on June 28, 2024.
• Linda Stacy was appointed as the company's Principal Financial Officer, while continuing her roles as Principal Accounting Officer and Secretary.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While the company reported a decrease in revenue and net income, they are making significant investments in technology and new products, and returning capital to shareholders. The appointment of a new PFO is also a positive development.

Positives

• The company returned a significant $18 million to stockholders through dividends and stock repurchases.
• NRC Health is investing in innovation and growth, with $4 million allocated to these areas in the first quarter.
• The company has strong cash flow from operations and access to additional liquidity through its line of credit and delayed draw term facility.
• The company is focused on product innovation and expects to increase funding for these investments throughout the year.
• The company is expanding its product suite and incorporating AI into its solutions.

Negatives

• Revenue decreased to $35.3 million in the first quarter of 2024, compared to $36.5 million in the same period last year.
• Net income decreased to $6.4 million in the first quarter of 2024, compared to $7.0 million in the first quarter of 2023.
• The company has approximately $40 million of net debt.

Risks

• The company's forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially.
• The company faces competition and financial pressures in the healthcare industry.
• The company's investments in technology and new products may not yield the expected returns.
• The company's debt level could pose a risk if not managed effectively.

Future Outlook

The company expects to continue building its AI and other technology capabilities, as well as its sales and thought leadership resources, while seeking operating efficiencies. They also plan to launch an expanded product suite and integrate AI across their products and business over time.

Management Comments

• Michael Hays, Chief Executive Officer, stated that NRC continues to be strongly positioned for growth in expanding markets.
• Michael Hays highlighted the company's decades of benchmarks and trusted thought leadership.
• Michael Hays mentioned the company's mission to enhance outcomes and experiences for everyone in the healthcare journey.
• Linda Stacy, Principal Financial Officer, commented on the significant investments made in technology, sales, and service teams.
• Linda Stacy stated that the company expects to continue building its AI and other technology capabilities.

Industry Context

The announcement reflects the broader trend in the healthcare industry where companies are focusing on enhancing patient experience, leveraging technology, and integrating AI to improve outcomes and operational efficiency. The company's focus on 'Human Understanding' aligns with the industry's move towards more personalized and patient-centric care.

Comparison to Industry Standards

• While specific competitor results are not provided, NRC Health's focus on patient experience and AI integration aligns with trends seen in companies like Press Ganey and Medallia, which also offer patient experience solutions.
• The decrease in revenue and net income could be a concern compared to industry leaders who are showing growth, but the company's investments in technology and new products could position them for future growth.
• The company's return of capital to shareholders through dividends and repurchases is a common practice among established companies in the healthcare technology sector, similar to companies like Cerner and Allscripts.

Management Changes

Stakeholder Impact

• Shareholders will receive a quarterly dividend of $0.12 per share.
• Shareholders also benefited from stock repurchases.
• Employees may be impacted by the company's investments in technology and new products.
• Customers may benefit from the company's expanded product suite and AI integration.
• The company's focus on 'Human Understanding' may improve patient outcomes and experiences.

Next Steps

• The company will launch an expanded product suite in the next quarter.
• The company will continue to integrate AI across its products and business.
• The company will hold a conference call on May 8, 2024, to discuss the first quarter results.
• The company will pay a quarterly cash dividend on July 15, 2024.

Key Dates

Keywords

NRC Health, Financial Results, First Quarter, Healthcare, Dividends, Stock Repurchases, Innovation, AI, Linda Stacy, Principal Financial Officer